SCHEMBL3485012

SCHEMBL3485012

O=C(O)c1ccc(CCC(C=Cc2ccccc2OCCCCCCc2ccccc2)Cc2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G4B P0C869 3/20 0.47
PTGER1 P34995 1/20 0.47
PTGER4 P35408 1/20 0.47
PTGER3 P43115 1/20 0.47
PTGER2 P43116 1/20 0.47
PDE4A P27815 3/20 0.46
PDE4B Q07343 3/20 0.46
PDE4C Q08493 3/20 0.46
PDE4D Q08499 3/20 0.46
PPARG P37231 2/20 0.42
KMT2A Q03164 2/20 0.42
KDM4E B2RXH2 1/20 0.42
PSMD14 O00487 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
CTDSP1 Q9GZU7 1/20 0.42
CYSLTR1 Q9Y271 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3484738 1.00 PLA2G4B (0.47) PLA2G4BPTGER1PTGER4PTGER3PTGER2
SCHEMBL3485010 1.00 PLA2G4B (0.47) PLA2G4BPTGER1PTGER4PTGER3PTGER2
SCHEMBL3484740 1.00 PLA2G4B (0.47) PLA2G4BPTGER1PTGER4PTGER3PTGER2
SCHEMBL3484264 0.99 PTGER1 (0.48) PLA2G4BPTGER1PTGER4PTGER3PTGER2
SCHEMBL3484259 0.99 PTGER1 (0.48) PLA2G4BPTGER1PTGER4PTGER3PTGER2
SCHEMBL3485351 0.96 PTGER1 (0.49) PLA2G4BPTGER1PTGER4PTGER3PTGER2
SCHEMBL3485347 0.96 PTGER1 (0.49) PLA2G4BPTGER1PTGER4PTGER3PTGER2
SCHEMBL8245132 0.95 KMT2A (0.44) PLA2G4BPTGER1PTGER4PTGER3PTGER2
SCHEMBL8243984 0.94 PDE4A (0.45) PLA2G4BPTGER1PTGER4PTGER3PTGER2
SCHEMBL3484753 0.92 TP53 (0.44) PLA2G4BKMT2AALDH1A1MAPTLTB4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029772-A1 Dicarboxylic Acid Derivatives and their Use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029772-A1 Dicarboxylic Acid Derivatives and their Use PC, SLC25A1, GOT2 PLA2G4B 4261/4885PTGER1 2299/4885PTGER4 2636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.